Transient elastography (FibroScan&reg;) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 32

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Aug 28, 2016; 22(32): 7236-7251
Published online Aug 28, 2016. doi: 10.3748/wjg.v22.i32.7236

Table 2 Advantages of transient elastography with controlled attenuation parameter

Most widely used and validated non-invasive technique

High range of values

Well defined quality criteria

Good reproducibility

Detects liver stiffness and steatosis from the same region of interest

Excellent for the exclusion of cirrhosis

Prognostic value in cirrhosis

User-friendly

Short duration, painless

Applicable as a screening method in large populations

Citation: Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan^®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251
URL: https://www.wjgnet.com/1007-9327/full/v22/i32/7236.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i32.7236

Mikolasevic I, Orlic L, Franjic N, Hauser G, Stimac D, Milic S. Transient elastography (FibroScan^®) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand? World J Gastroenterol 2016; 22(32): 7236-7251 [PMID: 27621571 DOI: 10.3748/wjg.v22.i32.7236]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.